Latest news

• Novavax to provide 1.1 billon COVID-19 vaccine doses to COVAX

  In addition, preliminary analysis found that the UK variant was detected in over 50% of the PCR-confirmed cases – with 32 cases being caused by the UK variant, 24 by the ... non-variant and six ‘unknown’.

• Rolling reviews of Novavax's COVID-19 vaccine begin across the globe

  In addition, preliminary analysis found that the UK variant was detected in over 50% of the PCR-confirmed cases – with 32 cases being caused by the UK variant, 24 by the ... non-variant and six ‘unknown’.

• UK trial of Novavax COVID-19 vaccine demonstrates 89.3% efficacy

  In addition, preliminary analysis found that the UK variant was detected in over 50% of the PCR-confirmed cases – with 32 cases being caused by the UK variant, 24 by the ... non-variant and six ‘unknown’.

• Generic Copaxone launches in US

  In a statement, Novartis said that Sandoz will offer "financial assistance to qualified patients, personalised injection training and 24-hour access to nurses for non-clinical questions" as part of the

• BMS' Opdivo backed as melanoma therapy in EU

  FDA approval as a second-line non-small cell lung cancer (NSCLC) therapy - a much larger market opportunity - in March. ... Vanda Pharmaceuticals got the go-ahead for Hetlioz (tasimelteon) for the treatment of non-24-hour sleep wake disorder in totally